Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de George Scangos
Age : 72
Public asset : 142,324,977 USD
Country of residence : Unknown
Linked companies : Agilent Technologies, Inc. - Vir Biotechnology, Inc.

Biography of George Scangos 
George A. Scangos is a businessperson who has been the head of 10 different companies and currently occupies the position of President, Chief Executive Officer & Director at Vir Biotechnology, Inc. He is also Member-National Board of Visitor at the University of California and on the board of 5 other companies. In his past career George A. Scangos held the position of Director at Decibel Therapeutics, Inc., Chief Executive Officer & Director at Biogen, Inc. Chief Executive Officer at Biogen Idec New Ventures, Inc. and Chief Executive Officer of Biogen Idec, Inc. (North Carolina) (both are subsidiaries of Biogen, Inc.), President, Chief Executive Officer & Director at Exelixis, Inc., President for Bayer Biotechnology, Chairman of Anadys Pharmaceuticals, Inc., Chairman of California Healthcare Institute, Senior Vice President-Research & Development at Bayer, Inc., President-Biotechnology Division at Bayer Corp., Chairman for Pharmaceutical Research & Manufacturers of America and Professor at The Johns Hopkins University. He received a doctorate from the University of Massachusetts and an undergraduate degree from Cornell University.


Current positions of George Scangos 
Holdings of George Scangos 
George Scangos : Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
More news


© 2022 People and Ownership :   
George Scangos : Connections 


Latest news about George Scangos 
04/27Transcript : Vir Biotechnology, Inc. - Special Call
CI
02/10Vir Biotechnology Says Sotrovimab Retains Neutralizing Activity Against Omicron BA.2 Subvariant
MT
02/08Vir Biotechnology, Inc. Appoints Johanna Friedl-Naderer as Executive Vice President and Chief Business Officer, Global, Effective March 2, 2022
CI
01/11Transcript : Vir Biotechnology, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 01:30 PM
CI
2021Transcript : Vir Biotechnology, Inc. - Special Call
CI
2021GSK says tests indicate antibody drug works against Omicron
RE
2021GSK says tests indicate antibody drug works against Omicron
RE
More news